Emerging roles of lysophosphatidic acid receptor subtype 5 (LPAR5) in inflammatory diseases and cancer.

Dacheux, Mélanie A; Norman, Derek D; Tigyi, Gábor J; Lee, Sue Chin

Dacheux, Mélanie A; Norman, Derek D; Tigyi, Gábor J; Lee, Sue Chin.

Afiliación

Dacheux MA; Department of Physiology, College of Medicine, University of Tennessee Health Science Center (UTHSC), Memphis, TN, United States of America.
Norman DD; Department of Physiology, College of Medicine, University of Tennessee Health Science Center (UTHSC), Memphis, TN, United States of America.
Tigyi GJ; Department of Physiology, College of Medicine, University of Tennessee Health Science Center (UTHSC), Memphis, TN, United States of America.
Lee SC; Department of Physiology, College of Medicine, University of Tennessee Health Science Center (UTHSC), Memphis, TN, United States of America. Electronic address: slee84@uthsc.edu.

Pharmacol Ther ; 245: 108414, 2023 05.

Article en En | MEDLINE | ID: mdl-37061203

Asunto(s)

Neoplasias; Receptores del Ácido Lisofosfatídico; Humanos; Neoplasias/tratamiento farmacológico; Transducción de Señal/fisiología; Lisofosfolípidos/metabolismo; Proliferación Celular; Dolor

Palabras clave

Cancer; Inflammation; Lysophosphatidic acid; Lysophosphatidic acid receptor; Tumor immunity; Wound healing

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores del Ácido Lisofosfatídico / Neoplasias Tipo de estudio: Qualitative_research Límite: Humans Idioma: En Revista: Pharmacol Ther Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google